JERRY NEWMAN: Open Payments
NPI 1962401760 · CLEVELAND, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$704 in 40 payments from 5 companies in 2025. Trend: 2023 $805 · 2024 $875 · 2025 $704
Food & beverage: $704
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 14 | $294 |
| Teva Pharmaceuticals USA, Inc. | 12 | $193 |
| Vanda Pharmaceuticals Inc. | 11 | $167 |
| Janssen Pharmaceuticals, Inc | 2 | $44 |
| Corium, LLC | 1 | $6 |
Products named: INGREZZA, AUSTEDO XR, FANAPT, INVEGA SUSTENNA, UZEDY, Azstarys.
Industry payments across TN — which companies pay providers there.
